Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Real-World Disease-Free Survival (DFS) in Nonmetastatic Non-small Cell Lung Cancer (NSCLC): A German I-O Optimise Analysis

A. Waldmann, C. Leal,M. J. Schoemaker,N. Niklas, L. Labohm,H. Baltus,C. Rault,M. J. Daumont, G. Emanuel, M. Muwaffak, V. Saglimbene,S. Lucherini,L. Vo,A. Katalinic

Journal of Thoracic Oncology（2023）

Cited 0|Views5
No score
Abstract
In patients with resectable NSCLC, the risk of disease recurrence and death following surgery remains high despite (neo)adjuvant treatment with systemic anti-cancer therapy (SACT). The objective of this study was to characterise disease-free survival (DFS) after surgery for patients with resectable non-metastatic NSCLC who received (neo)adjuvant SACT (chemotherapy/ chemoradiotherapy) using data from 4 cancer registries in Germany.
More
Translated text
Key words
Disease-free survival,Adjuvant/neoadjuvant treatment,Real-world evidence
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined